Le Lézard
Classified in: Science and technology
Subject: Merger/Acquisition

BioConnect Acquires Silent Partner Technologies to Expand Offerings for Intelligent Asset Tracking and Inventory Management to Bring Security and Accountability to Critical Assets Ranging From Controlled Narcotics to First Responder Gear


BioConnect has acquired Silent Partner Technologies, Inc. (SPT), headquartered in Tampa Florida ? a leading provider of RFID Inventory and Asset management software, expanding BioConnect's leading Trusted Security Platform to create the most advanced cloud based smart safes, smart lockers, smart cabinets, smart rooms and smart vehicles for the intelligent "chain of custody" and security assurance for any critical asset.

Portfolios of both companies complement each other perfectly.

"Bringing security and accountability to assets ranging from Narcotics and Controlled Goods to First Responder Gear and IT assets is becoming increasingly critical in today's environment and in particular eliminating Drug Diversion feeding the Opioid crisis. With the acquisition of Silent Partner Technologies, together we will offer a simple cloud subscription to upgrade any area protecting assets to become the next generation ?Smart Space' solution. Customers looking for higher security and ?chain of custody' accountability to protect their critical assets will find this solution very compelling," commented Rob Douglas, Founder and CEO of BioConnect. "BioConnect plus Silent Partner Technologies place the combined company in the leadership quadrant for Securing Things."

The Fire and EMS market for BioConnect has grown at 100% year over year since the purchase of MedixSafe in 2021 and the company remains committed to an "American Made" footprint and will operate this new line of business under Ryan Mueller the 13-year veteran of BioConnect and newly appointed General Manager.

"MedixSafe and SPT both have a significant installation base with EMS & Fire agencies and those customers will benefit from the unification under BioConnect's Trust platform," Rob Douglas continued, "I'm also excited to congratulate Ryan Mueller on his promotion to General Manager to lead this business unit, Ryan has a wealth of experience at BioConnect over the last 13 years leading customer experience, professional services and delivery and is ideal to spearhead the integration and expansion of this new business for us."

About BioConnect:

Built by IT professionals for IT professionals, BioConnect provides an enterprise biometric and multi-factor authentication & security platform to establish stronger identity trust for the protection of the most valuable enterprise assets, their people, data and assets. For four consecutive years, BioConnect's Trust Platform has received innovation awards from the Security Industry Association (SIA) and the 2023 EMS Innovation Award; along with being named a top quadrant leader in Access Control by Frost & Sullivan in 2022. Founded in Toronto, Canada in 2010, fast forward to today with over 18,000 active subscription customers predominantly in the USA and over 60 integration and strategic partnerships with leading security industry providers such as AMAG, Assa Abloy, Brivo, Cisco, Convergint, Genetec, HID, Johnson Controls, Lenel, and Software House.

In 2021, MedixSafe was purchased by BioConnect, a long time MedixSafe partner and supplier of biometric (fingerprint) solutions for secure access to MedixSafe devices. Together BioConnect and MedixSafe are uniquely positioned to offer solutions to the toughest security problems that an organization faces, providing security at scale that establishes a strong level of trust by unifying a person's identity across physical, IoT and digital applications.


These press releases may also interest you

at 07:40
DC BLOX, a premier provider of connected data centers and fiber network solutions in the Southeast U.S., announced that its new dark fiber route connecting its Myrtle Beach Cable Landing Station (CLS) to Atlanta has been completed. This unique...

at 07:35
Agenus Inc. ("Agenus") , a leader in discovering and developing novel immunological agents to treat various cancers, today announced it will conduct a Type B End-of-Phase 2 (EOP2) meeting in July with the U.S. Food and Drug Administration (FDA) to...

at 07:35
Zai Lab Limited today announced that members of the Company's senior management team will participate in the following investor conferences in May and June 2024: J.P. Morgan 20th Annual Global China Summit Panel Discussion: Thursday, May 23, 2024,...

at 07:35
Camunda today announced the addition of key capabilities focused on bringing even more AI value to its end-to-end process orchestration platform to further simplify and accelerate the ability to drive lasting value, transformative efficiencies and...

at 07:35
Wikifri, an insurance consulting firm and provider of the Insurance Daylight Data Solution, today announced its role in supporting Trium Cyber US Services, Inc. (Trium), a US-based Lloyd's coverholder and underwriter, in expanding their insurance...

at 07:35
Johnson & Johnson announced today that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in cash, with...



News published on and distributed by: